Search

everythinglearnresearchcommunity

for

Search:↓

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Janus kinase inhibitors may help treat lichen planopilaris.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Lack of functional CYLD in mice leads to early aging and cancer.

Targeted cancer therapies often cause serious skin problems that need careful management.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.